A Safety and Immunogenicity Study in Long-term Treatment of Eculizumab (JSC "GENERIUM", Russian Federation)

计划入组 50 人 · 首次发布于 2020 年 12 月 22 日

Study of Pharmacokinetics, Pharmacodynamics and Safety Assessment of GNR-044 (JSC GENERIUM, Russia) and Xolair®

计划入组 84 人 · 首次发布于 2020 年 10 月 23 日

Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction

计划入组 180 人 · 首次发布于 2025 年 8 月 28 日

Somatropin biosimilar (Pharmstandard/Masterclone/CJSC Generium)

Natalizumab Biosimilar (Generium)

Romiplostim biosimilar(Generium)

GENERIUM, AO

Russia

Genericus, Inc.

United States

MERCK GENERICS

Lebanon

Rossium Subsidiary Seeks Russian Registration for Second Canakinumab Biosimilar After Belarus Approval

Promomed to Invest 1.4 Billion Roubles in Small-Batch Production of Rare Disease Drugs

Generic Drug Industry Transformation: Biosimilars and Complex Generics Drive New Growth for Sandoz, Teva, and Viatris